Literature DB >> 12688363

B3/A3 rearrangement in a patient with chronic myeloid leukemia.

César Paz-Y-Miño, Melissa Arévalo, Paola E Leone.   

Abstract

The role of BCR/ABL isoforms and their relationships to leukemia phenotype are discussed continuously because of the variety of information reported. Here we describe a man with CML an atypical b3/a3 rearrangement, who had a good response to INFalpha treatment. This may be due to a deletion of the ABL exon 2 sequences, which are an essential part of the ABL SH3 domain inducing STAT5 expression, which is indeed crucial for the BCR/ABL leukemogenesis; because of its role in anti-apoptotic activity and cell cycle progress.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12688363     DOI: 10.1080/1042819021000029678

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  3 in total

1.  How to detect the rare BCR-ABL (e14a3) transcript: A case report and literature review.

Authors:  Lin-Hui Hu; Lian-Fang Pu; Dong-Dong Yang; Cui Zhang; Hui-Ping Wang; Yang-Yang Ding; Man-Man Li; Zhi-Min Zhai; Shudao Xiong
Journal:  Oncol Lett       Date:  2017-08-28       Impact factor: 2.967

2.  Genetics and genomic medicine in Ecuador.

Authors:  César Paz-Y-Miño; María J Guillen Sacoto; Paola E Leone
Journal:  Mol Genet Genomic Med       Date:  2015-12-21       Impact factor: 2.183

3.  A novel BCR-ABL1 fusion gene with genetic heterogeneity indicates a good prognosis in a chronic myeloid leukemia case.

Authors:  Fen Zhou; Runming Jin; Yu Hu; Heng Mei
Journal:  Mol Cytogenet       Date:  2017-05-19       Impact factor: 2.009

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.